Credit Suisse’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$124M Sell
1,549,136
-87,468
-5% -$6.68M 0.12% 155
2023
Q4
$129M Sell
1,636,604
-212,635
-11% -$15.1M 0.12% 150
2023
Q3
$129M Buy
1,849,239
+3,653
+0.2% +$259K 0.13% 145
2023
Q2
$128M Sell
1,845,586
-125,277
-6% -$8.91M 0.13% 155
2023
Q1
$146M Buy
1,970,863
+49,417
+3% +$4.14M 0.15% 135
2022
Q4
$179M Sell
1,921,446
-377,801
-16% -$36.5M 0.19% 98
2022
Q3
$219M Sell
2,299,247
-52,018
-2% -$5.15M 0.24% 73
2022
Q2
$218M Buy
2,351,265
+233,223
+11% +$22.8M 0.23% 73
2022
Q1
$214M Buy
2,118,042
+208,904
+11% +$21.9M 0.18% 99
2021
Q4
$197M Buy
1,909,138
+46,546
+2% +$4.3M 0.1% 184
2021
Q3
$158M Sell
1,862,592
-29,737
-2% -$2.49M 0.09% 227
2021
Q2
$158M Sell
1,892,329
-331,916
-15% -$27.2M 0.08% 246
2021
Q1
$167M Buy
2,224,245
+99,709
+5% +$7.26M 0.09% 254
2020
Q4
$145M Sell
2,124,536
-638,449
-23% -$41.5M 0.07% 293
2020
Q3
$161M Sell
2,762,985
-1,959,348
-41% -$122M 0.1% 216
2020
Q2
$307M Sell
4,722,333
-323,050
-6% -$20.3M 0.22% 84
2020
Q1
$299M Buy
5,045,383
+408,046
+9% +$27.2M 0.26% 64
2019
Q4
$345M Buy
4,637,337
+178,683
+4% +$12.5M 0.25% 61
2019
Q3
$281M Buy
4,458,654
+2,394,586
+116% +$142M 0.24% 69
2019
Q2
$112M Sell
2,064,068
-221,883
-10% -$11.9M 0.1% 195
2019
Q1
$123M Buy
2,285,951
+128,017
+6% +$7.9M 0.11% 162
2018
Q4
$141M Buy
2,157,934
+521,389
+32% +$38.9M 0.15% 128
2018
Q3
$129M Sell
1,636,545
-54,107
-3% -$3.87M 0.12% 158
2018
Q2
$109M Sell
1,690,652
-73,610
-4% -$4.85M 0.11% 174
2018
Q1
$110M Sell
1,764,262
-87,570
-5% -$6.28M 0.1% 191
2017
Q4
$134M Buy
1,851,832
+67,413
+4% +$4.9M 0.12% 147
2017
Q3
$145M Buy
1,784,419
+81,181
+5% +$6.42M 0.14% 136
2017
Q2
$137M Sell
1,703,238
-1,487,342
-47% -$117M 0.13% 137
2017
Q1
$250M Sell
3,190,580
-35,807
-1% -$2.86M 0.23% 81
2016
Q4
$255M Buy
3,226,387
+795,641
+33% +$64.4M 0.25% 67
2016
Q3
$216M Buy
2,430,746
+338,908
+16% +$32M 0.2% 89
2016
Q2
$200M Sell
2,091,838
-103,870
-5% -$10.4M 0.22% 83
2016
Q1
$228M Sell
2,195,708
-365,980
-14% -$35.6M 0.27% 66
2015
Q4
$250M Sell
2,561,688
-764,401
-23% -$74.9M 0.29% 66
2015
Q3
$321M Sell
3,326,089
-142,386
-4% -$15M 0.38% 41
2015
Q2
$364M Buy
3,468,475
+123,866
+4% +$12.7M 0.35% 44
2015
Q1
$345M Sell
3,344,609
-1,392,133
-29% -$141M 0.35% 48
2014
Q4
$456M Sell
4,736,742
-224,278
-5% -$19.8M 0.41% 35
2014
Q3
$395M Buy
4,961,020
+276,753
+6% +$21.8M 0.32% 49
2014
Q2
$353M Buy
4,684,267
+268,451
+6% +$20.3M 0.29% 56
2014
Q1
$331M Sell
4,415,816
-110,417
-2% -$7.8M 0.32% 51
2013
Q4
$324M Buy
4,526,233
+518,575
+13% +$33.3M 0.29% 51
2013
Q3
$227M Sell
4,007,658
-355,527
-8% -$21.2M 0.23% 71
2013
Q2
$249M Buy
+4,363,185
New +$253M 0.25% 60

Other funds holding CVS

Credit Suisse's CVS Position: Q1 2024 in Review

Credit Suisse reduced its CVS Health (CVS) stake by 5.3% in Q1 2024, selling an estimated $6.68M and leaving 1,549,136 shares worth $124M. The position accounts for 0.12% of the portfolio, ranked #155.

Credit Suisse first reported a position in CVS in Q2 2013 and has held it in 44 quarters since. The position peaked at $456M in Q4 2014. 2,176 funds tracked by Wall St. Rank hold CVS as of Q1 2024.

  • Credit Suisse held 1,549,136 shares of CVS Health worth $124M as of Q1 2024.
  • Credit Suisse sold 87,468 CVS Health shares in Q1 2024, an estimated $6.68M.
  • CVS Health made up 0.12% of Credit Suisse's portfolio in Q1 2024, its #155 holding.
  • Credit Suisse first reported a position in CVS Health in Q2 2013 and has held it in 44 quarters since.
  • Credit Suisse's CVS Health position peaked at $456M in Q4 2014.
  • 2,176 funds tracked by Wall St. Rank held CVS Health as of Q1 2024.

Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.